CLLS Message Board Post 9199692 | Cellectis S.A.
home / stock / clls / clls message board
Rhino_55
(investorshub)
Posted on: Dec/14/2022 08:39:18
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170689047
Cellectis Announces Positive Preliminary Clinical Data for UCART22
News, Short Squeeze, Breakout and More Instantly...
Cellectis S.A. Company Name:
CLLS Stock Symbol:
Market:
-
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology (ASH) 65th Annual Meeting • Execution of strategic collaboration and investment agreements with AstraZeneca ...
-
This novel editing approach might unlock new strategies for the treatment of metabolic and neurological diseases Non-viral circular ssDNA delive...
-
This novel editing approach might unlock new strategies for the treatment of metabolic and neurological diseases Non-viral circular ssDNA delivery associated to TALEN® gene editing allows high levels of gene insertion in long-term repopulating HSPCs NEW YORK, April 22, ...